Vnitr Lek 2014, 60(2):134-138

Renal denervation for treatment of arterial hypertension - the unanswered questions

Jitka Seidlerová1,3,*, Jiří Koza2,3, Ivo Bernat2,3, Richard Rokyta2,3, Vratislav Pechman2,3, Jan Filipovský1,3
1 Centrum pro výzkum a léčbu arteriální hypertenze, II. interní klinika LF UK v Plzni a FN Plzeň, přednosta prof. MUDr. Jan Filipovský, CSc.
2 Kardiologické oddělení FN Plzeň, přednosta prof. MUDr. Richard Rokyta, Ph.D.
3 Komplexní kardiovaskulární centrum FN Plzeň

Despite the extensive armamentarium of antihypertensive medication available, the control of hypertension remains poor. Therefore any possibilities of non-pharmacological treatment of resistant hypertension are welcome. Recently, close attention was paid to renal denervation. Present work summarizes the scientific reports and clinical trials related to this topic published so far and addresses the unanswered questions. Moreover, it also contains brief summary of authors' own experience with the method.

Keywords: renal denervation; resistant hypertension; sympathetic nervous system

Received: September 10, 2013; Accepted: October 30, 2013; Published: February 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Seidlerová J, Koza J, Bernat I, Rokyta R, Pechman V, Filipovský J. Renal denervation for treatment of arterial hypertension - the unanswered questions. Vnitr Lek. 2014;60(2):134-138.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cífková R, Bruthans J, Adámková V et al. Prevalence základních kardiovaskulárních rizikových faktorů v české populaci v letech 2006-2009. Studie Czech post-MONICA. Cor et Vasa 2011; 53(4-5): 220-229. Go to original source...
    2. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31(7): 1281-1357. Go to original source... Go to PubMed...
    3. de la Sierra A, Segura J, Banegas JR et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011; 57(5): 898-902. Go to original source... Go to PubMed...
    4. Schlaich MP, Lambert E, Kaye DM et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 2004; 43(2): 169-175. Go to original source... Go to PubMed...
    5. Schlaich MP, Sobotka PA, Krum H et al. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009; 361(9): 932-934. Go to original source... Go to PubMed...
    6. Krum H, Schlaich M, Whitbourn R et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373(9671): 1275-1281. Go to original source... Go to PubMed...
    7. Esler MD, Krum H, Sobotka PA et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The SYMPLICITY HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376(9756): 1903-1909. Go to original source... Go to PubMed...
    8. Esler MD, Krum H, Schlaich M et al. Renal sympathetic denervation for treatment of drug-resistant hypertension. One-year results from the SYMPLICITY HTN-2 randomized controlled trial. Circulation 2012; 126(25): 2976-2982. Go to original source... Go to PubMed...
    9. SYMPLICITY HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011; 57(5): 911-917. Go to PubMed...
    10. Worthley SG, Tsioufis CP, Worthley MI et al. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J 2013; 34(28): 2132-2140. Go to original source... Go to PubMed...
    11. Filipovský J, Widimský jr. J, Ceral J et al. Diagnostické a léčebné postupy u arteriální hypertenze - verze 2012. Doporučení České společnosti pro hypertenzi. Vnitř Lék 2012; 58(10): 785-801. Go to PubMed...
    12. Ceral J, Habrdová V, Voříšek V et al. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy. Hypertens Res 2011; 34(1): 87-90. Go to original source... Go to PubMed...
    13. Sherrill B, Halpern M, Khan S et al. Single-pill vs. free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence. J Clin Hypertens 2011; 13(12): 898-909. Go to original source... Go to PubMed...
    14. Jung O, Gechter JL, Wunder C et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens 2013; 31(4): 766-774. Go to original source... Go to PubMed...
    15. Hansen TW, Kikuya M, Thijs L et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens 2007; 25(8): 1554-1564. Go to original source... Go to PubMed...
    16. Staessen JA, Thijs L, Ohkubo T et al. Thirty years of research on diagnostic and therapeutic thresholds for the self-measured blood pressure at home. Blood Press Monit 2008; 13(6): 352-365. Go to original source... Go to PubMed...
    17. Templin C, Jaguszewski M, Ghadri JR et al. Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity® catheter system and the EnligHTNTM multi-electrode renal denervation catheter. Eur Heart J 2013; 34(28): 2141-2148. Go to original source... Go to PubMed...
    18. Steigerwald K, Titova A, Malle C et al. Morphological assessment of renal arteries after radiofrequency catheter-based sympathetic denervation in a porcine model. J Hypertens 2012; 30(11): 2230-2239. Go to original source... Go to PubMed...
    19. Rippy MK, Zarins D, Barman NC et al. Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol 2011; 100(12): 1095-1101. Go to original source... Go to PubMed...
    20. Brinkmann J, Heusser K, Schmidt BM et al. Catheter-based renal nerve ablation and centrally generated sympathetic activity indifficult-to-control hypertensive patients: prospective case series. Hypertens 2012; 60(6): 1485-1490. Go to original source... Go to PubMed...
    21. Widimský P, Filipovský J, Widimský jr. J et al. Odborné stanovisko České kardiologické společnosti a České společnosti pro hypertenzi k provádění katetrizačních renálních denervací (RDN) v České republice. Cor et Vasa 2012; 54(3-4): 155-159. Go to original source...
    22. Persu A, Renkin J, Thijs L et al. Renal Denervation: Ultima ratio or standard in treatment-resistant hypertension. Hypertens 2012; 60(3): 596-606. Go to original source... Go to PubMed...
    23. Kandzari DE, Bhatt DL, Sobotka PA et al. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol 2012; 35(9): 528-535. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.